High feasibility and antileukemic efficacy of fludarabine, cytarabine and idarubicin (FLAI) induction followed by risk‐oriented consolidation: A critical review of a ten‐year, single‐centre experience in younger, non m3 AML patients

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - April 15, 2016 Category: Hematology Authors: Fabio Guolo, Paola Minetto, Marino Clavio, Maurizio Miglino, Carmen Di Grazia, Filippo Ballerini, Giordana Pastori, Daniela Guardo, Nicoletta Colombo, Annalisa Kunkl, Giuseppina Fugazza, Barbara Rebesco, Mario Sessarego, Roberto Massimo Lemoli, Andrea Bac Tags: Research Article Source Type: research